2010 Neurological Institute Outcomes - Cleveland Clinic
2010 Neurological Institute Outcomes - Cleveland Clinic
2010 Neurological Institute Outcomes - Cleveland Clinic
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
82<br />
Neuromuscular Disorders<br />
Quality of Life in Myasthenia Gravis Patients (N = 26)<br />
<strong>2010</strong><br />
Mean MG-QOL15 Score<br />
25<br />
20<br />
15<br />
10<br />
5<br />
0<br />
Mean MG-ADL Score<br />
5<br />
4<br />
3<br />
2<br />
1<br />
0<br />
First Last<br />
Visit<br />
Myasthenia Gravis Functional Status (N = 95)<br />
2009 – <strong>2010</strong><br />
First Last<br />
Visit<br />
The MG-QOL15 is a quality-of-life<br />
questionnaire specific to myasthenia<br />
gravis (MG) that assesses both physical<br />
and psychological aspects of function.<br />
The MG-QOL15 has been shown to<br />
correlate well with clinical outcomes<br />
using physician impression as the gold<br />
standard. There is a reduction in mean<br />
MG-QOL15 from first to last visit. Average<br />
time between visits was 88 days.<br />
The MG-ADL profile is a simple eightitem<br />
questionnaire that focuses on<br />
common symptoms reported in MG.<br />
The graph shows the average score of<br />
95 patients with MG who were seen in<br />
the outpatient clinic by neuromuscular<br />
staff and who had complete MG-ADL<br />
assessments on at least two occasions<br />
in 2009-<strong>2010</strong>. There was a significant<br />
reduction in MG-related symptoms<br />
(P < 0.0001). Average time between<br />
visits was 189 days. Higher scores<br />
indicate greater disability.<br />
<strong>Outcomes</strong> <strong>2010</strong>